Summary
20.84 0.48(2.33%)11/22/2024
Avantor Inc. (AVTR)
AVTR reported last earnings on 2024-10-25 after the market. An EPS of $0.26 was observed compared to an estimated EPS of $0.25, resulting in a surprise value of $0.01. A revenue of $1,714 million was observed compared to an estimated revenue of $1,722 million, resulting in a surprise value of $-8 Million.
Avantor Inc. (AVTR)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
| 2.76 | 1.41 | -12.82 | -16.73 | -15.97 | 3.71 | 21.42 | 43.69 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
Earnings
Fundamental Ratings
| Category | Rating |
| Main Rating | B- |
| Recommended Rating | Neutral |
| DCF | Buy |
| ROE | Buy |
| ROA | Buy |
| Debt/Equity | Strong Sell |
| P/E | Strong Sell |
| P/B | Strong Sell |
| Trading Data | ||
| Close | 20.84 | |
| Open | 20.25 | |
| High | 20.85 | |
| Low | 20.25 | |
| Volume | 4,472,545 | |
| Change | 0.56 | |
| Change % | 2.76 | |
| Avg Volume (20 Days) | 5,356,575 | |
| Volume/Avg Volume (20 Days) Ratio | 0.83 | |
| 52 Week Range | 19.59 - 28.00 | |
| Price vs 52 Week High | -25.59% | |
| Price vs 52 Week Low | 6.36% | |
| Range | 2.89 | |
| Gap Up/Down | -0.21 | |
Fundamentals | ||
| Market Capitalization (Mln) | 15,820 | |
| EBIDTA | 1,396,999,936 | |
| PE Ratio | 48.4577 | |
| PEG Ratio | 0.0000 | |
| WallStreet Target Price | 45.37 | |
| Book Value | 5.0890 | |
| Earnings Per Share | 0.7910 | |
| EPS Estimate Current Quarter | 0.3200 | |
| EPS Estimate Next Quarter | 0.3300 | |
| EPS Estimate Current Year | 1.3900 | |
| EPS Estimate Next Year | 1.5400 | |
| Diluted EPS (TTM) | 0.7910 | |
| Revenues | ||
| Profit Marging | 0.0729 | |
| Operating Marging (TTM) | 0.1403 | |
| Return on asset (TTM) | 0.0576 | |
| Return on equity (TTM) | 0.1593 | |
| Revenue TTM | 7,269,400,064 | |
| Revenue per share TTM | 12.4740 | |
| Quarterly Revenue Growth (YOY) | 0.1430 | |
| Quarterly Earnings Growth (YOY) | 2.1400 | |
| Gross Profit (TTM) | 2,080,500,000 | |
| Dividends | ||
| Dividend Share | 0.0000 | |
| Dividend Yield | ||
| Valuations | ||
| Trailing PE | 48.4577 | |
| Forward PE | 24.9377 | |
| Price Sales (TTM) | 0.0000 | |
| Price Book (MRQ) | 7.7334 | |
| Revenue Enterprise Value | 4.0095 | |
| EBITDA Enterprise Value | 23.7117 | |
| Shares | ||
| Shares Outstanding | 609,452,992 | |
| Shares Float | 605,363,298 | |
| Shares Short | 0 | |
| Shares Short (Prior Month) | 0 | |
| Shares Ratio | 0.00 | |
| Short Outstanding (%) | 0.00 | |
| Short Float (%) | 0.00 | |
| Insider (%) | 1.63 | |
| Institutions (%) | 94.54 | |
11/20 08:05 EST - prnewswire.com
Avantor® to Participate in the 7th Annual Evercore ISI HealthCONx Conference
RADNOR, Pa. , Nov. 20, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that President and CEO, Michael Stubblefield, will be participating in a...
Avantor® to Participate in the 7th Annual Evercore ISI HealthCONx Conference
RADNOR, Pa. , Nov. 20, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that President and CEO, Michael Stubblefield, will be participating in a...
11/20 07:30 EST - businesswire.com
Avantor to Distribute Quantum-Si's Next-Generation Protein Sequencing™ Technology
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, has announced a distribution agreement with Avantor® (NYSE: AVTR), a global leader in mission-critical products and services for the life...
Avantor to Distribute Quantum-Si's Next-Generation Protein Sequencing™ Technology
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, has announced a distribution agreement with Avantor® (NYSE: AVTR), a global leader in mission-critical products and services for the life...
11/14 08:05 EST - prnewswire.com
Avantor® Opens New Bridgewater Innovation Center Focused on Solving Life Science's Biggest Challenges
RADNOR, Pa. , Nov. 14, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today announced the opening of its new flagship Bridgewater Innovation Center.
Avantor® Opens New Bridgewater Innovation Center Focused on Solving Life Science's Biggest Challenges
RADNOR, Pa. , Nov. 14, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today announced the opening of its new flagship Bridgewater Innovation Center.
11/07 12:40 EST - zacks.com
MD vs. AVTR: Which Stock Is the Better Value Option?
Investors looking for stocks in the Medical Services sector might want to consider either Pediatrix Medical Group (MD) or Avantor, Inc. (AVTR). But which of these two companies is the best option for those looking for undervalued stocks?
MD vs. AVTR: Which Stock Is the Better Value Option?
Investors looking for stocks in the Medical Services sector might want to consider either Pediatrix Medical Group (MD) or Avantor, Inc. (AVTR). But which of these two companies is the best option for those looking for undervalued stocks?
11/06 08:05 EST - prnewswire.com
Avantor® Appoints Dame Louise Makin, DBE, Ph.D., to its Board of Directors
RADNOR, Pa. , Nov. 6, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that the Avantor Board of Directors has appointed Dame Louise Makin, DBE, Ph.D.
Avantor® Appoints Dame Louise Makin, DBE, Ph.D., to its Board of Directors
RADNOR, Pa. , Nov. 6, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that the Avantor Board of Directors has appointed Dame Louise Makin, DBE, Ph.D.
10/28 15:05 EST - zacks.com
Avantor's Stock Declines Despite Q3 Earnings Beat, Margins Down
Despite AVTR's continued stability in the Education and Advanced Technology end markets, it reports an overall soft third-quarter performance.
Avantor's Stock Declines Despite Q3 Earnings Beat, Margins Down
Despite AVTR's continued stability in the Education and Advanced Technology end markets, it reports an overall soft third-quarter performance.
10/25 14:52 EST - seekingalpha.com
Avantor Inc. (AVTR) Q3 2024 Earnings Call Transcript
Avantor Inc. (NYSE:AVTR ) Q3 2024 Earnings Conference Call October 25, 2024 8:00 AM ET Company Participants Christina Jones - VP, IR Michael Stubblefield - President and Chief Executive Officer Brent Jones - Executive Vice President and Chief Financial Officer Conference Call Participants Daniel...
Avantor Inc. (AVTR) Q3 2024 Earnings Call Transcript
Avantor Inc. (NYSE:AVTR ) Q3 2024 Earnings Conference Call October 25, 2024 8:00 AM ET Company Participants Christina Jones - VP, IR Michael Stubblefield - President and Chief Executive Officer Brent Jones - Executive Vice President and Chief Financial Officer Conference Call Participants Daniel...
10/25 10:35 EST - zacks.com
Avantor (AVTR) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Avantor (AVTR) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Avantor (AVTR) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Avantor (AVTR) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
10/25 08:20 EST - zacks.com
Avantor, Inc. (AVTR) Beats Q3 Earnings Estimates
Avantor, Inc. (AVTR) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.25 per share. This compares to earnings of $0.25 per share a year ago.
Avantor, Inc. (AVTR) Beats Q3 Earnings Estimates
Avantor, Inc. (AVTR) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.25 per share. This compares to earnings of $0.25 per share a year ago.
10/25 06:05 EST - prnewswire.com
Avantor® Reports Third Quarter 2024 Results
Net sales of $1.71 billion, decrease of 0.3%; organic decline of 0.7% Net income of $57.8 million; Adjusted EBITDA of $302.5 million Diluted GAAP EPS of $0.08; adjusted EPS of $0.26 Operating cash flow of $244.8 million; free cash flow of $204.0 million RADNOR, Pa. , Oct. 25, 2024 /PRNewswire/ --...
Avantor® Reports Third Quarter 2024 Results
Net sales of $1.71 billion, decrease of 0.3%; organic decline of 0.7% Net income of $57.8 million; Adjusted EBITDA of $302.5 million Diluted GAAP EPS of $0.08; adjusted EPS of $0.26 Operating cash flow of $244.8 million; free cash flow of $204.0 million RADNOR, Pa. , Oct. 25, 2024 /PRNewswire/ --...
10/23 08:05 EST - prnewswire.com
Avantor® Strengthens Partnership with National Institute for Bioprocessing Research and Training (NIBRT) to Address Critical Biopharma Industry Challenges
Avantor and NIBRT have formed a new partnership to supply advanced Masterflex® equipment, essential products, and expert training to foster innovations in biopharma manufacturing RADNOR, Pa. , Oct. 23, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical...
Avantor® Strengthens Partnership with National Institute for Bioprocessing Research and Training (NIBRT) to Address Critical Biopharma Industry Challenges
Avantor and NIBRT have formed a new partnership to supply advanced Masterflex® equipment, essential products, and expert training to foster innovations in biopharma manufacturing RADNOR, Pa. , Oct. 23, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical...
10/21 14:30 EST - zacks.com
AVTR Stock Flat Following the Close of Divestiture Deal With Audax
Avantor closes its deal with Audax to divest its clinical services business.
AVTR Stock Flat Following the Close of Divestiture Deal With Audax
Avantor closes its deal with Audax to divest its clinical services business.
10/18 07:35 EST - businesswire.com
Audax Private Equity Completes Carveout of Avantor, Inc.'s Clinical Services Business and Rebrands the Company as Resonant Clinical Solutions
SAN FRANCISCO & BOSTON--(BUSINESS WIRE)--Audax Private Equity (“Audax”) has completed its acquisition of the clinical services business of Avantor, Inc. (NYSE: AVTR) and, in close collaboration with the employees, has re-branded the business as Resonant Clinical Solutions (“Resonant” or...
Audax Private Equity Completes Carveout of Avantor, Inc.'s Clinical Services Business and Rebrands the Company as Resonant Clinical Solutions
SAN FRANCISCO & BOSTON--(BUSINESS WIRE)--Audax Private Equity (“Audax”) has completed its acquisition of the clinical services business of Avantor, Inc. (NYSE: AVTR) and, in close collaboration with the employees, has re-branded the business as Resonant Clinical Solutions (“Resonant” or...
10/18 07:05 EST - prnewswire.com
Avantor® Closes Previously Announced Divestiture of its Clinical Services Business
RADNOR, Pa. , Oct. 18, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that it has closed the divestiture of its clinical services business to Audax...
Avantor® Closes Previously Announced Divestiture of its Clinical Services Business
RADNOR, Pa. , Oct. 18, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that it has closed the divestiture of its clinical services business to Audax...
10/02 12:46 EST - zacks.com
MD vs. AVTR: Which Stock Should Value Investors Buy Now?
Investors looking for stocks in the Medical Services sector might want to consider either Pediatrix Medical Group (MD) or Avantor, Inc. (AVTR). But which of these two stocks offers value investors a better bang for their buck right now?
MD vs. AVTR: Which Stock Should Value Investors Buy Now?
Investors looking for stocks in the Medical Services sector might want to consider either Pediatrix Medical Group (MD) or Avantor, Inc. (AVTR). But which of these two stocks offers value investors a better bang for their buck right now?
09/30 08:05 EST - prnewswire.com
Avantor® Wins Kaizen Institute Award for Excellence in Process Improvement and Quality Management
Recognition highlights commitment to Avantor Business System (ABS) principles to enhance customer experience RADNOR, Pa. , Sept. 30, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced...
Avantor® Wins Kaizen Institute Award for Excellence in Process Improvement and Quality Management
Recognition highlights commitment to Avantor Business System (ABS) principles to enhance customer experience RADNOR, Pa. , Sept. 30, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced...
09/27 08:05 EST - prnewswire.com
Avantor® to Host Third Quarter 2024 Earnings Call on Friday, October 25, 2024
RADNOR, Pa. , Sept. 27, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, will release its third quarter 2024 financial results before the market opens on Friday,...
Avantor® to Host Third Quarter 2024 Earnings Call on Friday, October 25, 2024
RADNOR, Pa. , Sept. 27, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, will release its third quarter 2024 financial results before the market opens on Friday,...
09/25 09:05 EST - prnewswire.com
Avantor® Joins Pharmaceutical Industry-Sponsored Energize Virtual Power Purchase Agreement
Reflects Growing Commitment to Renewable Energy Sources Energize virtual power purchase agreement will provide the equivalent of 25GWh of renewable energy annually beginning in 2026 Avantor continues to implement global solar installations, with more planned in 2025 RADNOR, Pa. , Sept. 25, 2024...
Avantor® Joins Pharmaceutical Industry-Sponsored Energize Virtual Power Purchase Agreement
Reflects Growing Commitment to Renewable Energy Sources Energize virtual power purchase agreement will provide the equivalent of 25GWh of renewable energy annually beginning in 2026 Avantor continues to implement global solar installations, with more planned in 2025 RADNOR, Pa. , Sept. 25, 2024...
09/23 08:05 EST - prnewswire.com
Avantor® Participates in BioProcess International 2024 Conference Scientific Program and Exhibition
RADNOR, Pa. , Sept. 23, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced the Company will deliver multiple scientific presentations and exhibit at...
Avantor® Participates in BioProcess International 2024 Conference Scientific Program and Exhibition
RADNOR, Pa. , Sept. 23, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced the Company will deliver multiple scientific presentations and exhibit at...
09/13 04:00 EST - seekingalpha.com
Broyhill's Q2 2024 Top Five Investments
Our top five investments—Avantor, Baxter, Fiserv, Nintendo, and Philip Morris—represented 50% of the equity portfolio, with mixed performance during the quarter. Avantor's shares rallied 26% in July after a strong earnings report, reaffirming full-year guidance and showing signs of industry...
Broyhill's Q2 2024 Top Five Investments
Our top five investments—Avantor, Baxter, Fiserv, Nintendo, and Philip Morris—represented 50% of the equity portfolio, with mixed performance during the quarter. Avantor's shares rallied 26% in July after a strong earnings report, reaffirming full-year guidance and showing signs of industry...